FTC
-
FTC challenges improper patents in FDA’s Orange Book, targeting pharma giants
USA —The United States’ financial regulator, the Federal Trade Commission (FTC), has initiated a crackdown on 10 companies, alleging that they have engaged in improper…
-
FTC halts Amgen’s Horizon Therapeutics acquisition amid antitrust concerns
USA — In a pivotal twist, the US Federal Trade Commission (FTC) has momentarily paused its challenge to Amgen’s proposed acquisition of Horizon Therapeutics. This…
-
FTC seeks to weigh in on Applied Medical’s antitrust lawsuit against Medtronic
USA — The U.S. Federal Trade Commission (FTC) has expressed its desire to intervene in Applied Medical Resources’ antitrust lawsuit against Medtronic, as it seeks…
-
Pfizer’s acquisition of Seagen faces regulatory hurdles as FTC review extended
USA — The Federal Trade Commission (FTC) has extended its review period for Pfizer’s proposed acquisition of cancer drug developer Seagen, adding four more weeks…
-
Illumina shareholders vote to oust Board Chair in Carl Icahn proxy battle
USA —In a significant development, activist investor Carl Icahn has successfully garnered enough support from Illumina shareholders to remove the biotech company’s board chair, John…
-
Federal Trade Commission takes strong stance against Amgen’s acquisition of Horizon Therapeutics
USA — The Federal Trade Commission (FTC) has made a bold move to block Amgen’s US$27.8 billion acquisition of Horizon Therapeutics, citing concerns about anti-competitive…
-
Illumina-Grail deal shut down by FTC to boost cancer test competition
USA — The Federal Trade Commission (FTC) has directed Illumina to divest its liquid biopsy developer Grail in a bid to eliminate antitrust concerns and…
-
Parkinson’s drug patent fight carries high stakes for patients, says FTC
USA — The patent dispute between Supernus and Sage Chemical over the Parkinson’s drug Apokyn has caught the attention of the Federal Trade Commission (FTC),…
-
FTC slaps GoodRx with US$1.5M fine in first action under health breach rule
USA —Online pharmacy GoodRx has agreed to pay US$1.5 million in civil penalties for years of sharing the health information of consumers with third parties…
-
FTC begins investigation of Amazon’s One Medical acquisition
USA – The Federal Trade Commission (FTC) has begun examining Amazon’s deal to purchase One Medical for US$3.9 billion, with the company operating clinics in…